38 Followers on Owler

TG Therapeutics

is a New York-based commercial-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of B-cell diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

TG Therapeutics

is a New York-based commercial-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of B-cell diseases... Read more
TG Therapeutics Chairman & CEO: Michael S. Weiss

Chairman & CEO

Michael S. Weiss

CEO Approval Rating

89/100

1993

PublicIndependent CompanyNASDAQTGTX

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2834 NAICS listing

Annual Revenue
$329M
Employees
290
Funding
$603.1M
Investments
1

News

Conference Presentation
Nov 29, 2024
Benzinga
TG Therapeutics to Participate in the Evercore HealthCONx Conference
Funding
Aug 06, 2024
Business Wire
TG Therapeutics received $250M in Post-IPO Debt Funding

TG Therapeutics Competitors

1Cabaletta Bio
2Cartesian
3Cellectis
4Verastem Oncology
5Epizyme
6Marengo
7Roche
8Bristol-Myers Squibb
9Vicore Pharma
10AltMed
Unlock 11 + competitors

Trending Companies